Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy.
Kristin LangRami A El ShafieSati AkbabaRonald KoschnyNina BougatfDenise BernhardtStefan E WelteSebastian AdebergMatthias HäfnerSteffen KargusPeter K PlinkertJuergen DebusStefan RiekenPublished in: Cancer management and research (2020)
Underweight patients and those with preexisting dysphagia should be closely screened during RT for weight loss and decreased oral intake. For weight loss greater than 4.5% during the treatment of HNC, early PEG-tube placement should be considered. Further prospective studies are needed to confirm these findings, and delineate a scoring system for timing of PEG use (prophylactic vs reactive) as well as assess the quality of life in patients with HNC who receive PEG placement.
Keyphrases
- ultrasound guided
- weight loss
- drug delivery
- bariatric surgery
- end stage renal disease
- newly diagnosed
- roux en y gastric bypass
- chronic kidney disease
- ejection fraction
- early stage
- gastric bypass
- radiation therapy
- prognostic factors
- weight gain
- squamous cell carcinoma
- type diabetes
- minimally invasive
- locally advanced
- patient reported outcomes
- adipose tissue
- combination therapy
- rectal cancer
- case control
- patient reported